Davis Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.45K Buy
58
+37
+176% +$4.33K ﹤0.01% 288
2026
Q1
$2.53K Hold
21
﹤0.01% 284
2025
Q4
$2.21K Hold
21
﹤0.01% 297
2025
Q3
$1.76K Buy
+21
New +$1.73K ﹤0.01% 305
2025
Q1
$27.6K Sell
307
-1,986
-87% -$185K 0.02% 172
2024
Q4
$228K Sell
2,293
-506
-18% -$52.2K 0.19% 77
2024
Q3
$318K Buy
2,799
+379
+16% +$45K 0.25% 70
2024
Q2
$310K Sell
2,420
-101
-4% -$13K 0.27% 68
2024
Q1
$330K Buy
2,521
+581
+30% +$71.6K 0.29% 66
2023
Q4
$211K Buy
+1,940
New +$201K 0.2% 71
2020
Q2
$12K Buy
166
+1
+0.6% +$75 0.02% 181
2020
Q1
$12K Buy
+165
New +$13K 0.03% 177

Other funds holding MRK

Davis Capital Management's MRK Position: Q2 2026 in Review

Davis Capital Management increased its Merck (MRK) stake by 176% in Q2 2026, buying an estimated $4.33K and bringing the position to 58 shares worth $7.45K. The position accounts for ﹤0.01% of the portfolio, ranked #288.

Davis Capital Management first reported a position in MRK in Q1 2020 and has held it in 12 quarters since. The position peaked at $330K in Q1 2024. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Davis Capital Management held 58 shares of Merck worth $7.45K as of Q2 2026.
  • Davis Capital Management bought 37 Merck shares in Q2 2026, an estimated $4.33K.
  • Merck made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2026, its #288 holding.
  • Davis Capital Management first reported a position in Merck in Q1 2020 and has held it in 12 quarters since.
  • Davis Capital Management's Merck position peaked at $330K in Q1 2024.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.